Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix

International Journal of Gynecological Pathology

Volumn 20, Issue 2, 2001, Pages 177-185

  Riethdorf, Sabine ^a,b   Riethdorf, Lutz ^a,b   Schulz, Gudrun ^a,b   Ikenberg, Hans ^a,b   Jänicke, Fritz ^a,b   Löning, Thomas ^a,b   Park, Tjoung Won ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

HPV 16 and HPV 18; Telomerase activity; Telomerase RNA; Viral oncogenes E6 E7

Indexed keywords

RNA; TELOMERASE;

ARTICLE; CARCINOGENESIS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; ONCOGENE E6; ONCOGENE E7; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS ONCOGENE; WART VIRUS;

EID: 0035085614     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200104000-00011     Document Type: Article

References (44)

1. Estimates of the worldwide mortality from 25 major cancers in 1990
2. Precancerous lesions of the cervix
3. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
4. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: Analysis by in situ hybridization
5. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: Activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q
6. Human papillomavirus DNAs immortalize normal human mammary epithelial cell differentiation in vitro
7. Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype
8. Telomerase activation by the E6 gene product of human papillomavirus type 16
9. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length
10. Telomeres and telomerase: At the end, it all comes together
11. Molecular pathogenesis of aging and cancer: Are telomeres and telomerase the connection?
12. Telomerase activation in cervical cancer
13. Telomerase activity and human papillomavirus in malignant, premalignant and benign cervical lesions
14. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions
15. Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer
16. Telomerase activity and expression of its RNA component in cervical lesions
17. Differential telomerase activity, expression of the telomerase catalytic sub-unit and telomerase-RNA in ovarian tumors
18. Telomerase activity in normal human epithelial cells
19. Specific association of human telomerase activity with immortal cells and cancer
20. Telomerase activity in normal and neoplastic breast
21. The RNA component of human telomerase
22. In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma
23. Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas
24. Telomerase activity and in situ telomerase RNA expression in malignant and nonmalignant lymph nodes
25. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
26. Telomerase catalytic subunit homologs from fission yeast and human
27. Human telomerase contains evolutionarily conserved catalytic and structural subunits
28. The telomerase reverse transcriptase: Components and regulation
29. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uter
30. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer
31. Telomerase activity and human papillomavirus (HPV) infection in human uterine cervical cancers and cervical smears
32. Clinical significance of telomerase activation and telomeric restriction fragment (TRF) in cervical cancer
33. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: Strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA
34. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor derived cell lines
35. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types
36. Association between HPV type and clonal status of cervical squamous intraepithelial lesions (SIL)
37. Molecular biology of cervical cancers and its precursors
38. Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability
39. Runaway telomere elongation caused by telomerase RNA gene mutations
40. Expression profile of the putative catalytic subunit of telomerase gene
41. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas
42. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization
43. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues
44. Expression of the MCP-1 gene and the HPV 16 E6/E7 oncogenes in squamous cell carcinomas of the cervix uteri and metastases